Search results
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 4 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
How Much Will Pfizer Pay Out in Dividends This Year?
Motley Fool via Yahoo Finance· 19 hours agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (NYSE: PFE) a household name in recent years, but this isn't all the company ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 3 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters via Yahoo Finance· 5 days agoInvestors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19 ...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 4 days agoShares of Novavax which makes a Covid-19 vaccine, were up 6.3%. Even vaccine stalwarts like GSK and...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 3 days agoUnlike the COVID-19 pandemic, when the U.S. government subsidized private companies to make the COVID...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company ...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 5 days agoVaccine manufacturers Novavax and Pfizer said via email they planned to assess their accessibility...
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
CNBC· 4 days agoPfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 6 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...